ARMGO Pharma has received a research grant from the Kennedy's Disease Association (KDA) to support preclinical work on new, orally available compounds that have potential as a novel treatment for Kennedy's Disease (KD) also known as spinal ...
Tags: Kennedy's Disease, ARMGO Pharma
Approximately one year after the company landed FDA approval for its Ventricular Assist System, the company is boasting significant surge in revenue. In early morning trading on November 7, the company's shares increased by 15%. In total, ...
US-based Abbott Laboratories has obtained an approval from the US Food and Drug Administration (FDA) for its MitraClip device, designed to treat patients with significant symptomatic degenerative mitral regurgitation (MR) who are at ...
Tags: FDA Approval, Abbott
Belgian biotechnology firm Cardio3 BioSciences has secured approval from the Italian Medicines Agency (Agenzia Italiana del Farmaco) to start its congestive heart failure cardiopoietic regenerative therapy (CHART-1) European Phase III trial ...
Tags: Cardio3 Biosciences, C-Cure Drug
US-based Critical Diagnostics has unveiled its Aspect-LF ST2 test, a point-of-care version of its lab-based Presage ST2 Assay. Aspect-LF will be made available throughout Europe and select Asia-Pacific countries later 2013. Aspect-LF is ...
US-based CardioKinetix has announced the successful treatment of first two Chinese heart failure patients with its Parachute ventricular partitioning device, a minimally invasive treatment for patients with heart failure caused by damage to ...
Tags: CardioKinetix, Partitioning Device
The US Food and Drug Administration (FDA) advisory panel has recommended the expanded indication of Medtronic’s cardiac resynchronization therapy-pacemakers and -defibrillators (CRT-P and CRT-D) for the treatment of patients who ...
ResMed, a developer of medical equipment for respiratory disorders, has enrolled 1,325 patients in SERVE-HF, an international, randomized study designed to determine sleep-disordered breathing in heart failure patients. The study will ...
Tags: ResMed, Serve-HF Study
Biotronik has unveiled the results from the IN-TIME study, a first randomized, controlled trial designed to assess the influence of Biotronik Home Monitoring on all-cause mortality in heart failure patients at the ESC (European Society of ...
CardioKinetix has announced the first successful procedure in four cardiac patients with its new catheter-based Parachute ventricular partitioning device in Kuala Lumpur, Malaysia. The new Parachute device is a new minimally invasive ...
Respicardia, a US-based developer of implantable therapies, has announced the enrollment of the first patients in the pivotal trial to evaluate the remede system in patients with central sleep apnea (CSA). The Respicardia pivotal trial is ...
Tags: Respicardia, Patient Enrollment
Medtronic, a US-based manufacturer of implantable heart-rhythm devices, has acquired Cardiocom, a disease-management and patient-monitoring firm, in a $200m all-cash deal. Cardiocom is a manufacturer of glucose monitors and weight scales ...
Tags: Medtronic, heart-rhythm devices
US-based medical device company St Jude Medical has commenced its EnligHTNment clinical study. The EnligHTNment study will assess whether the EnligHTN Multi-Electrode Renal Denervation System can minimize the risk of major cardiovascular ...
Tags: St Jude Medical, Clinical Study
The US Food and Drug Administration (FDA) has approved Thoratec's HeartMate II Pocket Controller, the safe face of the HeartMate II LVAD System. The Pocket Controller is lighter and compact than the previous LVAD system controllers, and ...
Medtronic's study has demonstrated that simultaneously pacing the lower chambers of the heart, or biventricular (BiV) pacing with a cardiac resynchronization therapy (CRT) device, significantly improves heart failure symptoms and quality of ...
Tags: CRT Device, Heart Failure Symptoms